Form 8-K - Current report:
SEC Accession No. 0001628280-24-035830
Filing Date
2024-08-08
Accepted
2024-08-08 06:14:18
Documents
15
Period of Report
2024-08-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rmti-20240808.htm   iXBRL 8-K 32484
2 EX-99.1 rmtiq224earningspr-final8k.htm EX-99.1 201711
6 GRAPHIC image_0.jpg GRAPHIC 52008
  Complete submission text file 0001628280-24-035830.txt   445822

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rmti-20240808.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rmti-20240808_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rmti-20240808_pre.xml EX-101.PRE 12508
17 EXTRACTED XBRL INSTANCE DOCUMENT rmti-20240808_htm.xml XML 2708
Mailing Address 30142 WIXOM ROAD WIXOM MI 48393
Business Address 30142 WIXOM ROAD WIXOM MI 48393 8004493353
ROCKWELL MEDICAL, INC. (Filer) CIK: 0001041024 (see all company filings)

EIN.: 383317208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23661 | Film No.: 241185846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)